JP2007511500A5 - - Google Patents

Download PDF

Info

Publication number
JP2007511500A5
JP2007511500A5 JP2006538977A JP2006538977A JP2007511500A5 JP 2007511500 A5 JP2007511500 A5 JP 2007511500A5 JP 2006538977 A JP2006538977 A JP 2006538977A JP 2006538977 A JP2006538977 A JP 2006538977A JP 2007511500 A5 JP2007511500 A5 JP 2007511500A5
Authority
JP
Japan
Prior art keywords
solid amorphous
compound
dispersion
weight
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2006538977A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007511500A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2004/003581 external-priority patent/WO2005046644A1/en
Publication of JP2007511500A publication Critical patent/JP2007511500A/ja
Publication of JP2007511500A5 publication Critical patent/JP2007511500A5/ja
Abandoned legal-status Critical Current

Links

JP2006538977A 2003-11-14 2004-11-01 肥満治療のためのmtp阻害剤の固体非晶性分散体 Abandoned JP2007511500A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51993103P 2003-11-14 2003-11-14
PCT/IB2004/003581 WO2005046644A1 (en) 2003-11-14 2004-11-01 Solid amorphous dispersions of an mtp inhibitor for treatment of obesity

Publications (2)

Publication Number Publication Date
JP2007511500A JP2007511500A (ja) 2007-05-10
JP2007511500A5 true JP2007511500A5 (enExample) 2007-12-20

Family

ID=34590458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006538977A Abandoned JP2007511500A (ja) 2003-11-14 2004-11-01 肥満治療のためのmtp阻害剤の固体非晶性分散体

Country Status (16)

Country Link
US (1) US20080293801A1 (enExample)
EP (1) EP1696887A1 (enExample)
JP (1) JP2007511500A (enExample)
KR (1) KR20060096076A (enExample)
CN (1) CN1878538A (enExample)
AR (1) AR048206A1 (enExample)
AU (1) AU2004289110A1 (enExample)
BR (1) BRPI0416596A (enExample)
CA (1) CA2545443A1 (enExample)
CO (1) CO5690536A2 (enExample)
IL (1) IL175372A0 (enExample)
MX (1) MXPA06005489A (enExample)
NO (1) NO20062778L (enExample)
NZ (1) NZ546677A (enExample)
TW (1) TW200515909A (enExample)
WO (1) WO2005046644A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2631694A1 (en) 2005-12-15 2007-06-21 F. Hoffmann-La Roche Ag Pyrrolo[2,3-c]pyridine derivatives
WO2008090198A1 (en) * 2007-01-25 2008-07-31 Janssen Pharmaceutica Nv Use of mtp inhibitors for increasing levels of satiety hormones
EP2522657B1 (en) * 2010-01-06 2016-08-03 Takeda Pharmaceutical Company Limited Indole derivative
US8313774B1 (en) 2012-06-26 2012-11-20 Magnifica Inc. Oral solid composition
EP3861989A1 (en) * 2020-02-07 2021-08-11 Bayer Aktiengesellschaft Pharmaceutical composition containing regorafenib and a stabilizing agent
US12453728B1 (en) 2024-08-08 2025-10-28 Redux Therapeutics, Llc Compositions comprising inhibitors of microsomal triglyceride transfer protein and Apo-B secretion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4884235A (en) * 1988-07-19 1989-11-28 Thiele Alfred A Micromagnetic memory package
ES2111065T5 (es) * 1991-04-16 2005-06-16 Nippon Shinyaku Company, Limited Procedimiento para producir una dispersion solida.
US5340591A (en) * 1992-01-24 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
DE19504832A1 (de) * 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
ATE364374T1 (de) * 1997-08-11 2007-07-15 Pfizer Prod Inc Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
HRP20031051B1 (en) * 2001-06-28 2012-01-31 Pfizer Products Inc. Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
AR038375A1 (es) * 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo

Similar Documents

Publication Publication Date Title
JP2005281687A5 (enExample)
JP2012236837A5 (enExample)
JP2007517016A5 (enExample)
JP2013067635A5 (enExample)
JP2006515626A5 (enExample)
JP2014505740A5 (enExample)
JP2013529637A5 (enExample)
JP2007511500A5 (enExample)
JP2008513510A5 (enExample)
CN206070141U (zh) 一种可以降低水污染的布料清洗甩干一体机
JP2007502904A5 (enExample)
JP2008517059A5 (enExample)
JP2004532268A5 (enExample)
JP2005168451A5 (enExample)
JP2011507698A5 (enExample)
JP2008520696A5 (enExample)
JP2015533174A5 (enExample)
JP2006235302A5 (enExample)
JP2005517046A5 (enExample)
JP2005513126A5 (enExample)
CN201192212Y (zh) 吊式蚊帐架
CN203194350U (zh) 一种折叠式捕泥鳅笼具
CN201123331Y (zh) 蚊蝇拍
CN206273115U (zh) 一种捕鼠笼的机关触发装置
CN203493193U (zh) 新型折合式沙发床